Provider review
Sells a compounded GLP-1 without ever naming the molecule.
Its treatments are listed as "GLP-1 Injections" at $179 and "GLP-1 Tablets" at $249. Semaglutide and tirzepatide appear nowhere on that page — only in the Terms, which reserve the right to move you from one to the other without a new agreement.
Reviewed by Marcus Webb
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
At a glance
Visit MEDGmPharmacy
Not categorized
Labs
Not published as a routine requirement; its Terms allow a…
States
Not stated
Ranked on this board
Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking. MEDGm is not ranked on it — we have read what it publishes, not placed it in an order.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not confirmed
The catch — The starting figure is described as a first month, and no renewal price is published. Its FAQ says $179 covers your consultation, your report and your first month of medication; nothing states what the following months cost, and the Terms bill the whole subscription term up front. Separately, the three brand-name options are priced as a membership plus a cost the site never states, so "$99 MEMBERSHIP + COST" is not a price at all.
See plans at MEDGmPrices read from MEDGm's own site · September 2026
What they advertise
"STARTING AT $179 — GLP-1 Injections" and "STARTING AT $249 — GLP-1 Tablets" on its weight-loss page. Beside them, brand-name options priced as membership plus an unstated drug cost: "$99 MEMBERSHIP + COST" for Zepbound and for Wegovy, and "$171 MEMBERSHIP + COST" for Ozempic.
What you actually pay
$179 a month is the published starting figure for the injection and $249 for the tablet, and its FAQ describes the $179 as all-inclusive — covering the consultation, a metabolic report and "your first month of medication". What the second month costs is not published on any page. Running the questionnaire as far as it will go without an account produces no figure at all.
Money you will meet later
MEDGm, LLC is a Delaware company selling a compounded GLP-1 weight-loss program in all fifty states and the District of Columbia, with clinical care through OpenLoop Health. Its pharmacy disclosure is good — four compounding pharmacies named with addresses and phone numbers — and its program starts at $179 a month, which is competitive. Two things a buyer should know first. It never tells you which drug you are buying: the products are "GLP-1 Injections" and "GLP-1 Tablets", and the only place either molecule is named is the Terms, which reserve the right to switch you between them and keep charging. And its own footer says the site's text, images and the people appearing in its advertisements may be generated by artificial intelligence.
MEDGm is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our tirzepatide provider ranking. Nothing on this page is a performance claim.
MEDGm does not name the pharmacy that fills your prescription.
Named, with addresses — four of them. Its Terms list RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama, each with a street address and a phone number, and note the list may change. The category is stated as a class rather than per facility: compounded medications are prepared by state-licensed 503A or FDA-registered 503B pharmacies, so which applies to your order is not said. Clinical care comes from OpenLoop Health. ⚠ Those four pharmacies and that clinical network are the same ones Lean Meds names, so the two brands are not independent of each other on the layer that matters clinically.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
All fifty states and the District of Columbia, stated in its Terms and repeated in its state-coverage note, qualified with the caveat that some services may not be available everywhere. No exclusions are named.
The part they would rather you skipped
MEDGm sells you a prescription drug without telling you which drug it is. Its treatments are "GLP-1 Injections" at $179 and "GLP-1 Tablets" at $249; the words semaglutide and tirzepatide appear nowhere on that page, nowhere on the homepage, and nowhere in the questionnaire — only in the Terms, which then reserve the right to move you between them: a provider may decide a different molecule is appropriate, and "unless you cancel your subscription, your continued enrollment constitutes your consent to receive the Provider-recommended product", with charges continuing regardless of the change. The same Terms say your subscription is charged even in a period where you receive no medication at all, and that a clinician meets you only after you have paid. Then there is the footer, which is doing more work than any footer should: MEDGm discloses that the site's text and images "may be generated or enhanced using artificial intelligence technologies", that no warranty is made as to their accuracy or reliability, and that "individuals appearing in advertisements may be actors or artificial intelligence representing licensed providers and are not medical professionals" — printed beneath a page of five-star testimonials, a "+20k VERIFIED REVIEWS" badge and named patients with photographs and pound counts.
None of this is unique to MEDGm — the whole category shares it.
The providers we rank on our tirzepatide provider ranking, in the order that board ranks them. MEDGm is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
140 more providers rank on our tirzepatide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check MEDGm's current pricing before you decide. Ours was read from their own site in September 2026.
Facts on this page reflect MEDGm's own public disclosures when we last checked them, in September 2026. Prices and terms change without notice — confirm on MEDGm's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
MEDGm
See current pricing